| Autor: |
Geng HJ; Institute of Basic Reserach in Clinical Medicine, China Academy of Chinese Medical Sciences Beijing 100700, China., Xie YM; Institute of Basic Reserach in Clinical Medicine, China Academy of Chinese Medical Sciences Beijing 100700, China., Zhang M; School of Statistics, Renmin University of China Beijing 100872, China. |
| Jazyk: |
čínština |
| Zdroj: |
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica [Zhongguo Zhong Yao Za Zhi] 2020 Jul; Vol. 45 (14), pp. 3324-3330. |
| DOI: |
10.19540/j.cnki.cjcmm.20200325.501 |
| Abstrakt: |
In this study, Tabu search algorithm was used to analyze the drug combination of Xingnaojing Injection in the treatment of brain injury and complications in the real world, and the clinical drug combination of Xingnaojing Injection in the treatment of brain injury and complications was selected and summarized. The combination of Xingnaojing Injection, Namefen and Citicoline were recommended in the treatment of brain injury and complications. For brain edema and nerve injury, Mannitol/Glycerol Fructose/Furosemide+Tetrahexose Monosialate Ganglioside Sodium should be recommended. For those with pulmonary infection, Xingnaojing Injection+Xiyanping+Ambroxol Hydrochloride+Tanreqing Injection should be recommended. For those with shock, Hydroxyethyl Starch+Dopamine Hydrochloride/Dobutamine Hydrochloride+Sodium Bicarbonate should be recommended. The combination reflected the characteristics of Chinese and Western medicine. The above medication regimen was only for clinicians' reference. The clinical application should be based on patients' specific conditions, clinical benefits and risks, as well as the incompatibility. On the basis of the findings, further studies can be carried out for prospective clinical efficacy evaluation and safety evaluation for a specific subgroup module. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
